PORTAL VEIN THROMBOSIS AND DUODENAL TUMOUR IN A PATIENT WITH MULTICENTRIC HEPATOCELLULAR CARCINOMA: CASE REPORT
Abstract:
The hepatocellular carcinoma (HCC) is the most common malignant hepatic tumour and also the main cause of death with an increasing incidence worldwide.(1) Despite the on-going progress of the prevention techniques, the screening and the new technologies of diagnosis and treatment, the incidence and mortality of these conditions continue to grow. Cirrhosis remains the most important risk factor for HCC development, regardless of etiology, while hepatitis B and C are independent risk factors for the occurrence of cirrhosis. Chronic consumption of ethanol remains an important supplementary risk factor, since alcohol abuse is five times more common than hepatitis C.(2) We hereby present the case of a patient with multicenter hepatocellular carcinoma whose condition has rapidly evolved unfavourably despite the antiviral therapy (portal vein thrombosis and duodenal tumour), thus limiting the therapeutic options.
full text article in English (.EN) |